Axsome Therapeutics (AXSM) EBT Margin (2022 - 2026)
Axsome Therapeutics (AXSM) recorded EBT Margin of -23.44% in Q2 2026, up 9.17 percentage points from -32.61% a year earlier and up 10.32 percentage points from the prior quarter.
Axsome Therapeutics (AXSM) EBT Margin (2022 - 2026) Analysis & Trends
On a TTM basis, Axsome Therapeutics' EBT Margin came in at -24.61% as of Jun 30, 2026, up 25.45 percentage points year-over-year; for FY2025, it came in at -28.77%, up 45.67 percentage points from FY2024.
- Annual EBT Margin has increased for three straight years, with a three-year change of +345.22 percentage points (FY2022 to FY2025).
- Across earlier years, EBT Margin came in at -74.45% in FY2024 (+13.61 pp), -88.06% in FY2023 (+285.94 pp) and -373.99% in FY2022.
- Quarterly EBT Margin has ranged from -469.82% in Q2 2022 to -9.13% in Q1 2023 over the past five years.
- On a year-over-year basis, EBT Margin has increased for nine consecutive quarters, with an average year-over-year change of +41.27 percentage points over the last eight quarters.
- Peak year-over-year performance for EBT Margin in the last five years was a gain of 324.66 percentage points in Q2 2023, against a drop of 82.01 percentage points in Q1 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at -33.76% (Q1 2026), -14.35% (Q4 2025) and -27.62% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 41.75% |
| 10 | Axsome Therapeutics | 10.14 Bn | 8.87 Bn | 204.81 Mn | -23.44% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -23.44% |
| Mar 31, 2026 | -33.76% |
| Dec 31, 2025 | -14.35% |
| Sep 30, 2025 | -27.62% |
| Jun 30, 2025 | -32.61% |
| Mar 31, 2025 | -48.91% |
| Dec 31, 2024 | -63.00% |
| Sep 30, 2024 | -61.67% |
| Jun 30, 2024 | -91.03% |
| Mar 31, 2024 | -91.14% |
| Dec 31, 2023 | -138.37% |
| Sep 30, 2023 | -108.80% |
| Jun 30, 2023 | -145.15% |
| Mar 31, 2023 | -9.13% |
| Dec 31, 2022 | -251.29% |
| Sep 30, 2022 | -266.08% |
| Jun 30, 2022 | -469.82% |
Axsome Therapeutics EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=AXSM&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "AXSM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=AXSM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();